Why the study?
Does moderate-to-severe MR predict cardiac death and HF in medically treated patients with LV dysfunction and FMR?
Does moderate-to-severe MR predict cardiac death and HF in medically treated patients with LV dysfunction and FMR?
Moderate-to-severe functional mitral regurgitation is an independent predictor of adverse outcomes (cardiac death and heart failure) in patients with LV dysfunction on standard pharmacological therapy.
Answers are grounded in this paper and cite their sources.
May inform prognosis in medically treated LV dysfunction with FMR; leaves open whether MR intervention improves outcomes.
The mortality and morbidity of patients with LV dysfunction and FMR remain high despite current standard pharmacological therapy. Moderate-to-severe MR is an independent predictor of cardiac death and HF.
No takes yet. Share an insight, caveat, or question.
Agricola et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: